Tylent Technologies to Present Lyvra™ at the GERPAC/ESHPT Conference in Hyères

Hyères, France — September 30–October 2, 2026

Tylent Technologies will present Lyvra™, its new platform for i.v. compounding automation, at the GERPAC/ESHPT Conference, taking place in Hyères, France, from September 30 to October 2, 2026.

The conference will provide an opportunity for hospital pharmacists and healthcare professionals to discover Lyvra™ and learn more about Tylent Technologies’ approach to IV compounding automation.

Designed and developed in Europe, Lyvra™ takes a process-first approach to automation, combining AI-driven workflow orchestration with advanced mechatronics to support scalable and integrated IV compounding workflows.

Visitors attending the conference are invited to meet the Tylent team, with meetings available in both French and English.

Private Technology Briefings

During the conference, Gaspar G. de Viedma, industry expert and advisor to Tylent Technologies, will host private technology briefings offering a deeper overview of the Lyvra™ platform, its architecture, and the principles behind its approach to IV compounding automation.

Attendance is by invitation only and requires pre-registration.

Those interested in arranging a private briefing may contact:

arturo.caissut@tylent-technologies.com

Event Details

GERPAC/ESHPT Conference
Hyères, France
September 30–October 2, 2026

More information about the congress is available at:

https://www.gerpac.eu/gerpac-conference

Next
Next

Tylent Technologies to Present Lyvra™ at the EAHP 30th Congress in Barcelona